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UPDATE ARTICLE
Irritability in children and adolescents: past concepts,
current debates, and future opportunities
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Irritability is defined as a low threshold to experience anger in response to frustration. It is one of the
most common symptoms in youth and is part of the clinical presentation of several disorders. Irritability
can present early in life and is a predictor of long-term psychopathology; yet, the diagnostic status of
irritability is a matter of intense debate. In the present article, we address two main components of the
debate regarding irritability in youth: the misdiagnosis of chronic irritability as pediatric bipolar
disorder, and the proposal of a new diagnosis in the DSM-5, disruptive mood dysregulation disorder,
whose defining symptoms are chronic irritability and temper outbursts.
Keywords: Irritability; disruptive behavior; mood; dysregulation; children; adolescents
Introduction
Irritability is defined as a low threshold to experience anger
in response to frustration. It is one of the most common
symptoms in youth and is part of the clinical presentation of
several disorders. Irritability can present early in life and is
a predictor of long-term psychosocial adversity; yet, the
diagnostic status of irritability is a matter of intense
debate.1 In the present article, we present a review of
two aspects of irritability in children and adolescents: 1)
The historical and theoretical background of the debate
regarding the association of irritability with youth bipolar
disorder (BD) and its role in the dramatic increase in the
rates of this disorder reported in recent years; 2) The
proposal of a new diagnostic category in the DSM-5 called
disruptive mood dysregulation disorder (DMDD), with
chronic irritability and temper outbursts as the defining
symptoms. Because the conceptualization of this entity is
a work in progress, we reviewed up-to-date clinical and
epidemiological data on DMDD.
The controversy about irritability and youth
bipolar diagnosis
Mental disorders are the result of maladaptive trajectories
throughout development.2 Approximately 80% of adult
mental disorders begin during childhood and adoles-
cence. In some cases, the same disorder is found in
different stages of development (homotypic continuity);
whereas in others the clinical phenotype changes with
development (heterotypic continuity).3 In recent years,
researchers have focused on identifying the develop-
mental trajectories of psychopathology, in the hope that
this could help clarify relevant aspects of etiology, course,
prognosis, prevention, and therapeutic strategies.4 BD is
a mood disorder that causes high levels of functional
impairment. Retrospective studies showed that in 50% of
cases BD begins during adolescence. Therefore, the
developmental trajectory of BD is of great interest for
researchers and clinicians.5
Between the mid 1990s and early 2000s in the United
States, there was a dramatic increase in the rate of
diagnosis of BD in children and adolescents, paralleling a
discussion in the professional literature about the
presentation of BD in youth.6 The proportion of bipolar
diagnosis of all psychiatric inpatient discharges in the
United States rose from 10 to 34% in children and from 10
to 49% in adolescents in 8 years. In 1996, there were 1.3
discharges with a bipolar diagnosis per 10,000 children
and adolescents in the general population, whereas in
2004 the ratio was 7.3 per 10,000, a five-fold increase. In
outpatient settings, the increase was approximately 40-
fold during that period.7 It is possible that youth BD was
previously underdiagnosed, explaining the increase in the
rates. However, another plausible explanation is a
change in the way the diagnostic criteria were applied,
leading to misdiagnosis of other conditions under the
label of BD.
BD is characterized by episodes of mania or hypoma-
nia, i.e., a distinct period of abnormally and persistently
elevated, expansive, or irritable mood (A symptoms)
accompanied by a number of cognitive, behavioral, and
physical symptoms (B symptoms) such as grandiosity,
decreased need for sleep, pressure of speech, increased
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goal-directed activities, flight of ideas, distractibility, and
psychomotor agitation. The concurrent presence of A and
B symptoms configures an episode of mania or hypoma-
nia; the difference between the two depends on the
intensity and duration of symptoms.8 Specifically, the
controversy in pediatric BD was focused on chronic,
nonepisodic irritability as a developmental presentation of
BD.9 Although the core definition of BD comprises an
episode, some researchers have suggested that mania in
youth presents as a nonepisodic, persistent, chronic, and
severe irritability.10-12 This shift in the concept of bipolar
illness has obvious implications in nosological classifica-
tion, prevalence, therapeutic approaches, and prognosis.
For instance, accepting youth BD as chronic and none-
pisodic leads to overlap of symptoms with other dis-
orders. For instance, distractibility, increased goal-
directed activities, pressure of speech, and psychomotor
agitation occur both in mania and attention deficit
hyperactivity disorder (ADHD). The episodicity of the
presentation was useful to differentiate BD and ADHD,
because while irritability is not a diagnostic criterion for
ADHD, temper outbursts and deficits in emotional
regulation (chronic irritability) are often seen in this entity.
Thus, defining BD in youth as chronic may then result in
many children with ADHD and irritability receiving the
diagnosis of BD, increasing the rates of comorbidity.
Therefore, the nonepisodic hypothesis of youth BD
kindled interest and concern among researchers, stimu-
lating research in the field.13
The considerations above show that the presentation of
irritability - chronic or episodic - is crucial for under-
standing its psychopathological meaning, particularly
because the constructs of episodic and chronic irritability
are separable and remain stable over time.14 For
instance, the correlation of episodic irritability between
early and late adolescence is 0.79, whereas that of
chronic irritability, is 0.56. However, the correlation
between episodic and chronic irritability is much lower,
0.34 in early and 0.26 in late adolescence.15 Thus,
chronic and episodic irritability seldom overlap but are
each relatively stable over time. Furthermore, the two
constructs present different associations with age: episo-
dic irritability has a linear association, whereas chronic
irritability presents a curvilinear trajectory, with a peak in
mid-adolescence. In addition, longitudinal associations
are also diverse between the two phenotypes: episodic
irritability in early adolescence is associated with general-
ized anxiety disorder (GAD), simple phobia, and mania in
late adolescence and only mania in early adulthood,
whereas chronic irritability in early adolescence is
associated with disruptive disorders in late adolescence
and only with major depressive disorder (MDD) in early
adulthood.15
In 2003, Leibenluft et al. proposed a systematization of
critical aspects of the youth bipolar debate, thus prompt-
ing research on the field16: 1) narrow phenotype,
including those patients who meet the full DSM-IV
diagnostic criteria for (hypo)mania, with hallmark symp-
toms of elevated mood and duration criterion (7 days for
mania; 4 days for hypomania); 2) (hypo)mania not
otherwise specified, featuring those who exhibit clear
episodes with elation as the hallmark symptom, but
duration between 1-3 days; 3) irritable (hypo)mania, in
which patients have a clear episode with irritability but not
elated mood as the main symptom; and 4) broad
phenotype, also called severe mood dysregulation
(SMD), characterized by chronic, nonepisodic illness,
and severe irritability.
Since then, several studies have established differ-
ences between the classical episodic bipolar phenotype
(BD) and those exhibiting chronic irritability and temper
outbursts (SMD). Whereas both groups show similar
levels of impairment on the Children’s Global Assessment
Scale (BD 51.1610; SMD 47.469, both indicating
moderate impairment), the BD group presents higher
rates of familial BD.17 To address the issue of whether
children with SMD would develop episodes of mania,
longitudinal analyses have been conducted. Irritability in
adolescence predicted MDD (odds ratio [OR] = 1.33, 95%
confidence interval [95%CI] 1-1.78), generalized anxiety
disorder (OR = 1.72, 95%CI 1.04-2.87), and dysthymia
(OR = 1.81, 95%CI 1.06-3.12). Youth irritability did not
predict BD at follow-up.18 Conversely, those with classical
BD, including an episodic course and elated mood, had
up to 50 times more chance to develop a manic episode
than those with SMD (i.e., chronic irritability) in a three-
year follow-up (BD 58/93 subjects - 62%; SMD 1/84
subjects - 1.2%).19 In addition, neuropsychological and
imaging data gave further contributions to the differentia-
tion between BD and chronic irritability.20-22
In short, there is definite evidence for a well-circum-
scribed entity characterized by episodic elated and/or
irritable mood and well-defined associated symptoms that
can be diagnosed as BD.23 This entity needs to be
identified clearly and treated appropriately because of a
high probability of poor outcomes throughout life.24
Conversely, patients identified as having chronic irrit-
ability should not be treated as exhibiting a develop-
mental manifestation of BD. Because the goal of this
review is pediatric irritability, we now move from the
controversy surrounding BD to focus on data addressing
specifically chronic irritability and emotional dysregulation
in children. We characterize clinical pictures whose main
symptoms are persistent irritability and temper outbursts
that are impairing in both the short and long term. We also
discuss functional burden, family history, neuropsycholo-
gical findings, and nosological uncertainties. We con-
clude addressing therapeutic strategies.
Chronic irritability, temper outbursts, and
disruptive mood dysregulation disorder
Irritability is defined as above, i.e., a deficit in emotional
regulation. Developmentally appropriate anger-related
behaviors tend to reflect frustration in expectable con-
texts, whereas chronic irritability is inappropriate to the
situation, i.e., stimuli that could be manageable elicit
intense responses manifested by reactive verbal and/or
physical aggression towards the perceived object of
threat or frustration. Deficits in emotional regulation are
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highly associated with psychopathology and one of the
most important predictors of mental disorders in cross-
sectional and longitudinal studies.25 Despite the impact of
emotional dysregulation on child and adolescent psycho-
pathology, it has no definite nosological home in the
current classificatory systems. Some efforts have been
made, but the phenotypic presentation of impairing
emotional dysregulation is still open and is an empirical
question. Currently, there are at least four different ways
to classify this group of children.
Firstly, SMD was proposed as a phenotypic differentia-
tion from BD. The diagnostic criteria comprised abnormal
mood (anger or sad, at least half of the day, most days),
frequent temper outbursts (three times/week), and
hyperarousal symptoms (three or more: insomnia,
agitation, distractibility, racing thoughts or flight of ideas,
pressured speech, and intrusiveness). Symptoms must
cause severe impairment in one setting (i.e., home,
school, peers) and mild impairment in a second setting,
must begin before 12 years of age and be present for at
least 12 months, without symptom-free periods exceed-
ing 2 months (Table 1). The research on SMD focused on
the differentiation from BD, and neuropsychological and
imaging data comparing the two entities clarified its
boundaries.26,27 Furthermore, research on SMD stressed
the importance of chronic irritability for developmental
psychiatry and suggested its adoption by the DSM-5. In
an epidemiological sample, lifetime prevalence for SMD
Table 1 Diagnostic criteria: SMD vs. DMDD
SMD DMDD
1. Compared to his/her peers, the child exhibits
markedly increased reactivity to negative
emotional stimuli that is manifest verbally or
behaviorally. For example, the child responds to
frustration with extended temper tantrums
(inappropriate for age and/or precipitating event),
verbal rages, and/or aggression toward people or
property. Such events occur, on average, at least
three times a week.
A. The disorder is characterized by severe recurrent temper outbursts that are grossly
out of proportion in intensity or duration to the situation.
1. The temper outbursts are manifest verbally and/or behaviorally, such as in the
form of verbal rages or physical aggression towards people or property.
2. The temper outbursts are inconsistent with developmental level.
2. Hyperarousal, as defined by at least three of
the following symptoms: insomnia, agitation,
distractibility, racing thoughts or flight of ideas,
pressured speech, intrusiveness.
B. Frequency: the temper outbursts occur, on average, three or more times per week.
3. Abnormal mood (specifically anger or
sadness), present at least half of the day most
days, and of sufficient severity to be noticeable
by people in the child’s environment (e.g.,
parents, teachers, peers).
C. Mood between temper outbursts:
1. Nearly every day, most of the day, the mood between temper outbursts is
persistently irritable or angry.
2. The irritable or angry mood is observable by others (e.g., parents, teachers,
peers).
4. The symptoms noted in 2-4 above are
currently present and have been present for at
least 12 months without any symptom-free
periods exceeding 2 months.
D. Duration: criteria A-C have been present for 12 or more months. Throughout that time,
the person has not had 3 or more consecutive months without the symptoms of criteria
A-C.
5. The symptoms are severe in at least one
setting (i.e., violent outbursts, assaultiveness at
home, school, or with peers). In addition, there
are at least mild symptoms (distractibility,
intrusiveness) in a second setting.
E. Criterion A or C is present in at least two settings (at home, at school, or with peers)
and must be severe in at least one setting.
6. Aged 7-17, with the onset of symptoms
before age 12.
F. The diagnosis should not be made for the first time before age 6 or after age 18.
G. The onset of criteria A through E is before age 10.
H. There has never been a distinct period lasting more than one day during which
abnormally elevated or expansive mood was present most of the day, and the
abnormally elevated or expansive mood was accompanied by the onset, or
worsening, of the three of the B criteria of mania (i.e., grandiosity or inflated self-
esteem, decreased need for sleep, pressured speech, flight of ideas, distractibility,
increase in goal directed activity, or excessive involvement in activities with a high
potential for painful consequences). Abnormally elevated mood should be
differentiated from developmentally appropriate mood elevation, such as occurs in
the context of a highly positive event or its anticipation.
I. The behaviors do not occur exclusively during an episode of major depressive
disorder and are not better accounted for by another mental disorder (e.g., autism
spectrum disorder, posttraumatic stress disorder, separation anxiety disorder,
dysthymic disorder).* The symptoms are not due to the effects of a drug or to a
general medical or neurological condition.
DMDD = disruptive mood dysregulation disorder; SMD = severe mood dysregulation.
* Note: This diagnosis cannot co-exist with oppositional defiant disorder or bipolar disorder, though it can co-exist with attention deficit
hyperactivity disorder and substance use disorders. Individuals meeting criteria for both DMDD and oppositional defiant disorder should only
be given the diagnosis of DMDD. If an individual has ever experienced a manic or hypomanic episode, the diagnosis of DMDD should not be
assigned.
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was 3.3%. Around 70% of SMD youth had a concomitant
axis I diagnosis, ADHD (27%), conduct disorder (CD)
(36%), and oppositional defiant disorder (ODD) (25%).
Moreover, those who met criteria for SMD at first wave
(mean age 10.661.4 years) were significantly more likely
to be diagnosed with a depressive disorder (OR = 7.2,
95%CI 1.3-38.8) at follow-up (mean age 18.362.1 years)
than youth who never met criteria for SMD.28
Secondly, the DSM-5 working group excluded the
hyperarousal criterion from SMD, since it overlapped with
ADHD symptoms,29 and proposed a new diagnostic
category called DMDD (Table 1). There is still little
evidence on DMDD and studies mostly construct the
phenotype based on other DSM-IV symptoms. Recently,
Copeland et al., using two community samples, sug-
gested prevalence rates of DMDD between 0.8 to 3.3%,
with higher rates in preschool aged and male individuals.
In the same study, DMDD significantly co-occurred with
all common psychiatric disorders. The highest levels of
co-occurrence were with depressive disorders (OR
between 9.9 and 23.5) and ODD (OR between 52.9 and
103.0). Only one case of DMDD overlapped with mania.
The likelihood of DMDD occurring alone ranged from 8%
to 38% (for comparison, conduct disorder occurred alone
64% of the time, and depression occurred alone in
36.6%). Besides, youth with DMDD experienced higher
levels of all social impairments and had elevated rates of
recent suspension compared with those without DMDD
criterion. These individuals were more likely to come from
impoverished families.30
In another study with a clinically referred sample -
n=706, aged 6-12 years, who participated in the
Longitudinal Assessment of Manic Symptoms (LAMS) -
high levels of overlap with other disorders were also
described.31 At intake, the DMDD phenotype was present
in 26% of patients. Nearly all subjects with DMDD (96%)
met criteria for ODD/CD and 77% met criteria for both
ODD and ADHD. Compared with those without the
phenotype, DMDD subjects presented higher rates of
disruptive behavior disorders, dysthymia, and ADHD as
well as higher scores on Young Mania Rating Scale
(YMRS), Children Depression Rating Scale (CDRS), and
ODD and CD subscales of the Child and Adolescent
Symptom Inventory. At a 12-month follow-up, only 53% of
those meeting criteria for DMDD at intake continued to
meet criteria. Of those meeting criteria at any assessment
(intake, 12-month, and 24-month follow-up), 52% did it
at only one assessment, 30% at two, and 20% at all
three time points. A diagnosis of DMDD at any time-point
was significantly associated with a diagnosis of ODD/CD
(71% of those with ODD also had DMDD vs. 3% without
ODD, p , 0.0001) and ADHD (44% of those with ADHD
also had DMDD vs. 23% without ADHD, p , 0.0001),
but there was no association with any depressive
disorder, any anxiety disorder, or BD. There was no
specific association between DMDD and family history
of mental disorders. The authors concluded that the
DMDD phenotype could not be clearly delimited from
ODD and CD and it showed limited longitudinal diagnostic
stability.
Thirdly, the Irritable dimension within the ODD diag-
nosis is characterized by temper outbursts, annoyance,
and touchiness.32 Similar to SMD, the Irritable dimension
shows strong association with emotionality.33,34
However, even though both share the same core
features, the assumption of SMD/DMDD as a specifier
of ODD (Irritable dimension) was considered insufficient
to describe the phenotype clinically. The DSM-5 Task
Force argued that a syndrome characterized by chronic
irritability, temper outbursts, and association with depres-
sive disorders should be labelled under a mood section
rather than a section on disruptive disorders, like ODD. In
a British sample, the Irritable dimension of ODD was the
only predictor of emotional disorders (anxiety and/or
depression) compared to the other ODD dimensions of
oppositionality, headstrong, and hurtful.32 The associa-
tion between Irritable dimension of ODD and internalizing
disorders was replicated in distinct samples and age
groups.35-37 Longitudinal data from the British national
survey (n=7,912) showed that the Irritable dimension of
ODD predicted emotional disorders at follow-up, particu-
larly distress disorders (depression and anxiety).18
Findings of shared genes between the Irritable dimension
of ODD and depressive disorders provided further
support of a developmental association between them.38
Moreover, the Irritable dimension of ODD showed a
strong association with maternal depression.39 The DSM-
5 subtyped ODD into three dimensions (1. Angry/Irritable
Mood; 2. Argumentative/Defiant Behavior; 3.
Vindictiveness),32 excluding the possibility of comorbidity
between DMDD and ODD. If ODD and DMDD co-occur,
DMDD should be the diagnosis given.
Fourthly, irritability as a dimension phenotype cutting
across diagnoses. This concept is in agreement with the
Research Domain Criteria of the National Institutes of
Mental Health (NIMH), which suggests that psychopatho-
logical mechanisms and new treatment targets should be
studied across diagnostic boundaries.40 Furthermore, this
perspective is consistent with the presence of chronic
irritability and temper outbursts in a wide range of
disorders, such as ADHD, ODD, and ASD.41,42 Indeed,
Wakschlag et al. found that around 80% of preschool-
aged children have temper loss, but only 8% have it
daily.43 Using Item Response Theory (IRT), the authors
psychometrically validated Temper loss as a dimensional
continuum ranging from normative misbehaviors to
problem indicators. Thus, quality as well as frequency
would contribute to a severity continuum. Indicators of
concern include daily tantrums, lasting more than 5
minutes, physical aggression during the tantrum, the
occurrence of a tantrum with nonparental adults, and the
presence of tantrums without a trigger. Although these
results were in preschoolers, thus too young for either the
SMD or DMDD diagnoses, they provide support for a
dimensional conceptualization.
Regardless of the classification applied, emotional
dysregulation has been described as a common compo-
nent of many developmental psychopathologies and a
strong predictor of both disruptive and mood syn-
dromes.44 Although empirical evidence supports emo-
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tional dysregulation as a continuum and a critical domain
of research, clinical decisions remain dependent upon
diagnostic categories. Driven by the concern regarding
BD misdiagnosis and focused on clinicians’ use, the
DSM-5 deliberations point towards the adoption of
DMDD. One can conclude at this time that not enough
scientific data about these children are available to create
a new diagnosis. However, we should agree on the
importance of this problem and the need to expand the
efforts to understand the complex construct of irritabil-
ity.45
In short, clinical assessment of a child presenting with
irritability and temper outbursts should always start with
active investigation of episodicity. Is it possible to
determine when the symptoms began? Have there been
significant changes relative to the child’s usual baseline
behavior? Did the changes occur in response to life
events? Have associated symptoms occurred along with
irritability? Is it possible to distinguish a clear episode of
irritable mood and its associated symptoms? In the case
of episodicity, proper assessment for BD should be
carried on. On the contrary, if irritability is considered
chronic, clinical investigation should turn towards emo-
tional dysregulation-based diagnoses (Figure 1). DMDD
phenotype should be considered if the child is described
as always irritable and angry, it is difficult to determine
when symptoms began (probably early in life), and
temper outbursts occur frequently. It is important to
evaluate triggering events, duration and intensity of
outbursts as well as settings where they usually occur
(home, with family, and peers). Children with the DMDD
phenotype present irritable or angry mood between
outbursts, characterized as sensitive to day-to-day
frustration and ordinary changes. In almost all cases,
these children will present with another diagnosis, ODD
being by far the most common (however, as specified
above, when the comorbidity between ODD and DMDD
occur, the latter should be given preference). Besides,
ADHD and anxiety disorders also commonly co-occur. Of
note, family history of psychopathology should be actively
assessed.
Research on measurement of irritability has been
limited. The Affective Reactivity Index (ARI), a scale that
contains six symptom items and one impairment item
about irritability, has been created to address this gap.
The scale focuses on three aspects of irritability over the
last 6 months: threshold for an angry reaction, frequency
of anger feelings/behaviors, and duration of such
feelings/behaviors. The ARI has excellent internal con-
sistency and external validation and can be used at both
research and clinical settings.46
Therapeutic strategies for chronic irritability
Taken together, evidence of functional impairment, early
onset, high morbidity, and wide spread comorbidity make
?
Figure 1 Assessment of irritability in children and adolescents
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emotional dysregulation a critical target for intervention.
Although little research has focused on the treatment of
SMD/DMDD, parent training and cognitive behavioral
therapy has shown promising results. Scott et al.
evaluated whether children presenting the irritable dimen-
sion of ODD would be more sensitive to the positive
effects of a parenting program than those without such a
profile.47 One hundred and twelve children, between 4-6
years, were randomized to the intervention (n=61) or
control group (n=51). Parental intervention covered
promotion of desirable child behavior through play,
praise, rewards, handling misbehavior, applying conse-
quences, and time out. Post hoc analyses indicated that
treatment effect was moderated by emotional dysregula-
tion. Although too young for meeting diagnostic criteria for
either SMD or DMDD, preschool children with emotional
dysregulation were more sensitive to changes in parent-
ing and showed significantly stronger treatment effect
than those without the phenotype.
Along these lines, Waxmonsky et al. proposed a group-
based psychosocial treatment integrating evidence-based
techniques of behavioral modification, anger manage-
ment, and CBT programs to target oppositional behaviors
and mood symptoms for children with ADHD plus SMD
(mean age: 8.762 years).48 The 9-week intervention
included parent sessions paralleled with child sessions
and promoted joint application of learned skills for the
whole family. Treatment had a large effect on the CDRS
(Cohen’s d 1.17), YMRS (Cohen’s d 0.81), and improved
Child Global Assessment Scale (CGAS: pretreatment
47.8667.5; posttreatment 66.43610.7). These findings
provide preliminary evidence for behavioral cognitive
interventions. Moreover, the inclusion of the parents in
the intervention seems crucial for treatment effectiveness.
Addressing pharmacological options for the treatment of
emotional dysregulation, the only placebo-controlled trial in
children with SMD found no benefit of lithium over
placebo.49 An open label trial using low doses (mean
1.260.5 mg) of risperidone in children and adolescents
with SMD showed significant reductions in irritability
scores (Aberrant Behavior Checklist-Irritability at baseline
25.89, standard error [SE] 2.7, and at week 8 11.28, SE
3.06, p , 0.001).50 Risperidone was also effective in
reducing duration of rage outbursts in inpatient settings
(baseline 44620 min, last dose 25612 min).51 Indeed,
risperidone is FDA approved for the treatment of irritability
in patients with autism spectrum disorders, although
irritability in autism may not be the same as the one found
in typically developing children. However, such findings
should be seen with caution, especially because of the
potential damaging side effects of antipsychotics in youth.
In addition, some studies show support for the use of
stimulants in patients exhibiting ADHD plus SMD symp-
toms. A study examining the effect of stimulants in children
with ADHD and SMD found the association to be safe and
to reduce externalizing symptoms.52 Studies examining
emotional liability in ADHD provide additional support for
the use of stimulants in this population.53 A randomized
controlled trial, conducted by the NIMH mood disorders
team using citalopram plus methylphenidate in children
with SMD, is under way. The rationale for use selective
serotonin reuptake inhibitors (SSRIs) in children with SMD
is the clear link between this phenotype and depressive
disorders. The concern of using antidepressants in these
children is no longer valid, since the boundaries with BD
are well established. There is, however, a clear need for
further studies on treatment strategies in children present-
ing with chronic irritability and temper outbursts.
Furthermore, as comorbidity seems to be the rule, trials
addressing therapeutic strategies according to comorbid
disorders are much needed.
Conclusion
Irritability has been surrounded by controversy in child
and adolescent psychiatry. First, the debate was driven
by the boundaries between chronic irritability and bipolar
diagnosis. Once the boundaries with BD were clarified,
the debate turned to the proposal of a new diagnosis
category, whose main symptom is emotional dysregula-
tion. Although evidence suggests a dimensional distribu-
tion across the pediatric population, the DSM-5 indicates
the adoption of DMDD as a new category entity. The
associations of emotional dysregulation phenotypes are
wide and include both internalizing and externalizing
disorders, but are mainly linked to depressive disorders.
Finally, treatment evidence includes cognitive behavioral
therapy, especially parental intervention, but there is a
pressing need for research on adjunctive pharmacologi-
cal treatment.
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